Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 279

Results For "market"

3570 News Found

Vestige launches nutritional supplement for women
Healthcare | March 10, 2022

Vestige launches nutritional supplement for women

It has blended 36 important ingredients for a woman’s health, which has a mix of natural extracts, amino acids, multivitamins and minerals


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts


Alvotech settles with AbbVie to secure US rights to Humira biosimilar
Biotech | March 09, 2022

Alvotech settles with AbbVie to secure US rights to Humira biosimilar

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023


Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry
Biotech | March 09, 2022

Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry

Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder


USFDA approves Evoke Spinal Cord Stimulation System
Drug Approval | March 09, 2022

USFDA approves Evoke Spinal Cord Stimulation System

Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment


Venus Remedies wins WHO GDP certification
Supply Chain | March 09, 2022

Venus Remedies wins WHO GDP certification

Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards


SII’s Covovax approved for 12-17 years age group
News | March 09, 2022

SII’s Covovax approved for 12-17 years age group

The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021


Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment
Drug Approval | March 08, 2022

Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment

Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis


Sense receives CE marking for Veros Covid-19 instrument-free molecular test
Medical Device | March 08, 2022

Sense receives CE marking for Veros Covid-19 instrument-free molecular test

Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions


Toyobo invests in US-based biotech startup DMC Biotechnologies
Startup | March 08, 2022

Toyobo invests in US-based biotech startup DMC Biotechnologies

Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts